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Abstract
To clarify the early pathological events in simian and human immunodeficiency chimeric virus (SHIV)-infected lymphoid organs, we
examined rhesus macaques infected with an acute pathogenic SHIV (SHIV89.6P) or a nonpathogenic SHIV (NM-3rN) by sequential
biopsies and serial necropsies. In the SHIV89.6P-infected monkeys, acute thymic involution as shown by increased cortical tingible-body
macrophages and by neutrophilic infiltrates without follicular aggregation in the medulla began within 14 days postinoculation (dpi). Cells
that were strongly positive for the virus were identified in the thymic medulla. SHIV89.6P-infected lymph nodes showed severe paracortical
lymphadenitis with scattered virus-positive cells at 14 dpi and they developed paracortical depletion without the obvious follicular
involution. In contrast, NM-3rN-infected monkeys showed no signs of thymic dysinvolution and the lymph nodes exhibited only follicular
hyperplasia. NM-3rN-infected monkeys showed much fewer virus-positive cells in these lymphoid tissues than did SHIV89.6P-infected
monkeys during the same period. These differences clearly reflect the difference in the virulence of these SHIVs.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Investigations of the early events in human immunode-
ficiency virus (HIV) infection can provide important clues
to understanding the resultant disease progression and prog-
nosis (Fauci, 1993; Graziosi et al., 1998; Pantaleo et al.,
1993). However, detailed studies of HIV-infected humans at
the early stage are extremely limited and even impossible to
conduct during the first few weeks (Madea et al., 1990;
Prevot et al., 1992). Simian immunodeficiency viruses
(SIVs) are closely related to HIVs and some of them are
known to cause a fatal disease in infected macaques similar
to those seen in human acquired immunodeficiency syn-
drome (AIDS) (Daniel et al., 1985; Letvin et al., 1985;
Letvin and King, 1990; Ringler et al., 1989; Wyand et al.,
1989). Extensive studies on the early infection course have
been done in macaques to help understand the early infec-
tion course in humans (Chakrabarti et al., 1994; Lackner et
al., 1994). However, the immune response of monkeys to
SIV envelope proteins is thought to be different from the
immune response of humans to HIV-1 (Weiss et al., 1986).
Thus, for developing anti-HIV-1 drugs and vaccines and for
evaluating their efficacy and safety, a new animal model
that utilizes the HIV-1 genes would be valuable.
To establish an experimental vaccination model using
HIV-1 and macaque monkeys, we have developed a series
of SIVmac/HIV-1 chimeric viruses (SHIVs) (Haga et al.,
1998; Igarashi et al., 1996, 1994; Sakuragi et al., 1992;
Shibata et al., 1991). One of these viruses, NM-3rN, carries
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the region of intact HIV-1 (NL432) that contains vpr, tat,
rev, vpu, and env (Kuwata et al., 1995). In human and
macaque peripheral blood mononuclear cells (PBMCs) as
well as in some human T-cell lines, NM-3rN replicated
effectively. Its replication was comparable to that of SIV-
mac239 in vitro. NM-3rN-infected monkeys exhibited vire-
mia and the virus was consistently reisolated from these
monkeys during the first several weeks postinfection. Nev-
ertheless, none of the infected monkeys showed significant
CD4 T cell depletion or developed AIDS during more
than three years of observation (Haga et al., 1998; Hayami
et al., 1999). Taken together, these results indicated that
NM-3rN should be classified as a persistently infecting but
nonpathogenic SHIV.
In addition to being used to develop HIV vaccine can-
didates, SHIVs have also been used in vivo to explore the
pathogenicity of HIV-1 (Harouse et al., 2001; Igarashi et al.,
1999; Joag et al., 1996; Reimann et al., 1996a). Reimann et
al. succeeded in developing the first pathogenic SHIV
(SHIV89.6P) by serial in vivo passages of the original
SHIV-89.6 strain (Reimann et al., 1996b). In contrast to
NM-3rN, SHIV89.6P replicated much less than SIVmac239
in macaque PBMCs but replicated well in vivo. The virus
caused a rapid and profound CD4 decline within a couple
of weeks and then caused miscellaneous opportunistic in-
fections. Thus, SHIV89.6P was considered an acute patho-
genic virus. In a postmortem histopathological examination
169 days postinoculation (dpi), Reimann et al. (1996a, b)
observed severe thymic dysinvolution and marked histio-
cytic paracortical expansion in the infected lymph nodes
(LNs). However, the mode of disease progression in the
early phase of infection was not clear.
The objective of this study was to clarify the early
pathological events in both acute pathogenic and nonpatho-
genic SHIV-infected lymphoid tissues. We inoculated
young rhesus macaques with the acute pathogenic
SHIV89.6P or the nonpathogenic NM-3rN and compared
the results with those obtained from monkeys infected with
a chronic pathogenic molecular clone, SIVmac239. We ex-
amined the animals by sequential biopsies and by serial
necropsies to explore the histopathology and virus distribu-
tion in the lymphoid organs. We observed distinct patho-
logical findings and distinct virus-positive cell populations
that reflect the marked difference of their virulence.
Results
Peripheral CD4 cell count and plasma virus load of
infected animals
In all four SHIV89.6P-infected monkeys, peripheral
blood CD4 T cells were depleted within 2 weeks (Fig. 1).
Two out of three SIVmac239-infected animals showed a
transient CD4 T cell decline while NM-3rN-infected ma-
caques did not show any significant change of CD4 T cell
counts. As the CD4 cells were declining in the
SHIV89.6P-infected monkeys, the viruses were actively
replicating. By the end of the second week, the viruses
reached their peak levels, more than 109 viral RNA copies
per milliliter. In contrast, the peak virus load in the NM-
3rN-infected monkeys was delayed and less than 107 cop-
ies/ml, while the peak titer of SIVmac239-infected monkeys
showed intermediate properties (the peak titer of the SIV-
mac239-infected monkeys at 7 dpi was lower than the peak
titer of SHIV89.6P-infected monkeys at 14 dpi but higher
than that of NM-3rN-infected monkeys at 18 or 23 dpi).
Acute infections with the inoculated viruses were also con-
firmed by virus reisolation at 14 and 21 dpi in all of these
animals.
Histopathological changes of the infected thymus
Both of the SHIV89.6P-infected monkeys that developed
AIDS (MM130 and MM131) had severe thymic involution
(Table 1). Figure 2A shows representative thymic alter-
ations at the AIDS stage caused by SHIV89.6P infection.
The thymic parenchyma showed complete obsolescence and
was replaced by aggregations of foamy histiocytes. Al-
though the thymuses of the two SIVmac239-infected ani-
mals (MM082 and MM105) showed moderate thymic in-
volution (Table 1 and Fig. 2B, left), they showed severe
pneumonia and Pneumocystis carinii pneumonia around
630 dpi and were judged as having AIDS (Fig. 2B, right). In
contrast to these pathogenic viruses, NM-3rN-infected mon-
keys did not show any symptoms associated with AIDS
during an observation period of more than 3 years (Table 1).
To understand how the virus-infected organs changed dur-
ing the early stage of infection, the SHIV89.6P-infected
thymuses were examined at 14 and 28 dpi. In both monkeys
necropsied at 14 dpi, we observed acute thymic involution
with a “starry sky” appearance in the cortex (Table 2, Fig.
3A, left and middle). The so-called starry sky appearance
was due to the abundance of tingible-body macrophages in
the cortex. This was consistent with our observation of a
significant increase of apoptotic cells in the infected cortex
at 14 dpi (Iida et al., 2000). Expansion of the medulla was
observed with infiltrations of neutrophilic inflammatory
cells that were associated with the nuclear debris of dead
cells (Fig. 3A, right). Subsequently, the continuous progres-
sion of thymic involution resulted in severe atrophy at 28
dpi (Table 2 and Fig. 3C, left). Thus, acute thymic involu-
tion began within 14 dpi and resulted in an accelerated
thymic atrophy. In contrast to the SHIV89.6P-infected an-
imals, neither the NM-3rN-infected animals nor the SIV-
mac239-infected animals developed thymic alterations to
such an extent within the observation periods (Table 2, Fig.
3C, middle and right). These findings in the SIVmac239-
infected thymuses were consistent with the findings of a
previous report (Lackner et al., 1994).
The tissue distribution of the virus-producing cells
(VPCs) in the infected thymuses was analyzed by histo-
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chemical in situ hybridization (HISH). As shown in Figs.
3B and 3C, in the SHIV89.6P-infected monkeys, the VPCs
were localized mainly in the thymic medulla at 14 and 28
dpi. At 14 dpi, the VPCs showed a spindle morphology and
were arranged in a network pattern adjacent to Hassall’s
corpuscles, while much fewer VPCs were observed in the
cortex (Fig. 3B). At 28 dpi, the VPCs were scattered in the
thymic medulla (Fig. 3C left). The appearance of these
VPCs was also associated with the cystic degeneration of
the Hassall’s corpuscles. In contrast to the pathogenic virus-
infected thymuses, the NM-3rN-infected thymuses had only
a few VPCs per section (Fig. 3C, middle). In the SIV-
mac239-infected animals, no obvious histological alteration
was observed but scattered VPCs with a small round mor-
phology were identified mainly in the medulla (Fig. 3C,
right).
Thymic epithelial cells of the SHIV89.6P-infected mon-
key, as observed with transparent electron microscopy
(TEM), were morphologically classified according to a pre-
vious description (Shimosato and Mukai, 1997) (Fig. 4).
Fig. 1. Kinetics of the peripheral CD4 cell counts and plasma virus loads in each of the virus-infected monkeys. These parameters were monitored during
the observation period of each monkey up to the day of sacrifice.
Table 1
Disease states of SHIV- and SIV-infected monkeys that were observed for periods of 6 months or more
Animal ID Inoculated virus Observation period Disease state
MM130 SHIV/89.6P, 10 TCID50 IVa 182 days AIDS
MM131 SHIV/89.6P, 10 TCID50 IV 287 days AIDS
MM043 SHIV/NM-3rN, 105 TCID50 IV 1239 days ACb
MM064 SHIV/NM-3rN, 105 TCID50 IV 1239 days AC
MM082 SIVmac239, 105 TCID50 IV 630 days AIDS
MM105 SIVmac239, 105 TCID50 IV 630 days AIDS
a IV, intravenous inoculation.
b AC, asymptomatic carrier.
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The dark epithelial cells (E4) adjacent to Hassall’s corpus-
cles (H) and the large medullary epithelial cells (E6) seemed
to be well preserved at 14 dpi (Fig. 4, left). At 28 dpi, the E4
cells were shrunken and the network structure was distorted
(Fig. 4, upper right). In contrast, the subcapsular E1 and
pale E2 cell network in the outer cortex seemed to be rather
preserved (Fig. 4, lower right). Thus, the disappearance of
the VPCs seemed to be in proportion to the disorganization
of the thymic medullary epithelial cells.
Histopathological changes of the infected lymph nodes
(LNs)
In the SHIV89.6P-infected LNs, remarkable morpho-
logic change was evident from 14 dpi (Table 3 and Fig. 5,
upper left). At 14 dpi, the infected nodes revealed a relative
paracortical expansion with infiltration of mixed cell types,
and there was a severe cell loss at 28 dpi (Fig. 5, lower left).
Unlike the HIV- and/or SIV-infected LNs, there was no
association of the florid follicular expansion followed by
severe involution and depletion. In contrast to the profound
CD4 T cell decline in the peripheral blood within 14 dpi,
the cell density in the LNs was rather constant. On the other
hand, the NM-3rN-infected LNs showed gradual paracorti-
cal expansion at 14 and 28 dpi (Table 3 and Fig. 5, middle).
The histology was consistent with chronic nonspecific
lymphadenitis and seemed to show mild lymphoid activa-
tion. Nevertheless, within this observation period, none of
the NM-3rN-infected LNs developed paracortical depletion
as the pathogenic SHIV89.6P-infected animals did. The
SIVmac239-infected animals exhibited paracortical expan-
sion and sinus histiocytosis at 28 dpi and did not develop the
florid follicular hyperplasia that was seen in the persistent
generalized lymphadenopathy (PGL) state (Table 3 and Fig.
5, right).
Most of the LNs examined by HISH showed VPCs. The
VPCs were mainly in the paracortex, but the ways in which
the distributions changed with time differed among the
viruses. As previously reported (Chakrabarti et al., 1994;
Lackner et al., 1994), in the SIVmac239-infected animals,
most of the VPCs were identified in the paracortex at 28 dpi
(Table 3 and Fig. 5, lower right). This was more frequent
Fig. 2. (A) Involuted thymus in the SHIV89.6P-infected monkey after developing AIDS (MM131). Hematoxylin- and eosin staining (H&E): left, 40; right,
400. (B) The involuted but not completely obsolescent thymus derived from a SIVmac239-infected monkey that developed AIDS (MM105; left, 40).
Right panel shows the lung of the same monkey. The terminal airways were filled by Pneumocystis carinii (H&E, 40).
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than that observed in thymic medulla (Fig. 3C, right). This
finding was also consistent with the findings of previous
reports (Karr et al., 1994). In the SHIV89.6P-infected LNs,
the VPCs transiently increased in number and intensity at 14
dpi and then decreased at 28 dpi. This seemed to be caused
by a massive cell loss in the paracortex (Table 3 and Fig. 5,
left). On the other hand, in the NM-3rN-infected LN, very
few VPCs were detected in the paracortex at 14 and 28 dpi
(Fig. 5, middle).
Histopathological changes of the infected spleen and
tonsils
It is thought that one of the functions of the spleen is to
protect individuals from blood-borne pathogens. The
splenocytes are also the target in humans infected with HIV
and in monkeys infected with SIV. As reported previously,
in the SIVmac239-infected spleen, the VPCs were mainly
identified in the periarteriolar lymphoid sheath (PALS),
which is a T-cell-dependent zone (Table 2). The
SHIV89.6P-infected spleens also exhibited a severe cell
loss of PALS at 28 dpi, apparently in parallel with the
paracortical depletions in the peripheral LNs. Half of the
SHIV89.6P-infected animals showed VPCs in the PALS. In
contrast, the NM-3rN-infected spleens exhibited few VPCs
distributed in the PALS and showed nonspecific lymphoid
activation but never exhibited severe cell loss during the
observation periods.
It has been reported that HIV-1-induced changes were
more accelerated in the tonsils than in the peripheral LN
(Wenig et al., 1996). In three SIVmac239-infected monkeys
that were tested in this study, the numbers of VPCs in the
tonsils were almost the same as the numbers seen in the
corresponding peripheral LNs (Tables 2 and 3). In the
SHIV89.6P-infected tonsils, there was clear depletion of
mononuclear cells in the paracortex by 28 dpi while only a
few VPCs were identified in the same area. On the other
hand, in the NM-3rN-infected tonsils, lymphoid activation
was the main feature and the frequency of the VPCs was as
low as it was in other lymphoid tissues. These findings seem
to be similar to what was observed in the paracortex of the
peripheral LNs.
Amount of proviral DNA in lymphoid tissues
The amounts of proviral DNA in some lymphoid tissues
of infected monkeys were examined by TaqMan PCR (Fig.
6). As expected, the amounts of proviral DNA of all tissues
examined were much higher in SHIV89.6P-infected mon-
keys than in NM-3rN-infected monkeys at all stages. The
amounts of proviral DNA in NM-3rN-infected lymphoid
tissues were kept at quite low levels during the observation
period. In both virus-infected monkeys, the amount of pro-
virus tended to be higher in the thymus than in the spleen
and mesenteric LNs at the acute phase of infection, while it
tended to be higher in mesenteric LNs at the late stage.
Discussion
The early stage of SHIV89.6P infection was clinically char-
acterized by rapid, profound, and continuous peripheral CD4
T cell depletion. Reimann et al. (1996a) observed severe thy-
mic dysinvolution (marked atrophy and thymocyte depletion
according to their designation) in SHIV89.6P-infected mon-
keys after 169 dpi. We also noted thymic atrophy and severe
paracortical depletion of the peripheral lymph nodes in animals
that had developed AIDS. However, the mode of disease
Table 2
Histopathology and distribution of virus-producing cells in infected lymphoid organs
Virus Animal ID dpi Thymus Spleen Tonsil
Histopath
C/M
HISH
C/M
Histopath
FL/PALS/RP
HISH
FL/PALS/RP
Histopath
FL/IF
HISH
FL/IF
SHIV89.6P MM180 14 TBM/IN / NP/HM/NP // NA NA
MM184 14 TBM/IN NA H/HM/NP // H/HM /
MM159 28 MA/SA / DP/DP/NP // DP/DP /
MM161 28 MA/SA / DP/DP/NP // NA NA
NM-3rN MM168 14 NP/NP / NP/HM/NP // H/HM /
MM172 14 NP/NP / H/HM/IN // H/HM /
MM139 28 NP/NP / H/NP/NP // H/HM /
MM157 28 NP/NP / NP/NP/NP // H/HM /
SIVmac239 MM2013 28 NA NA NP/NP/IN // H/HM /
MM2015 28 NP/NP / NP/HM/IN // NP/HM /
MM2019 28 NA NA H/HM/IN // H/HM /
Note. Abbreviations for anatomical sites: C, cortex; M, medulla; FL, follicles; PALS, periarteriolar lymphoid sheath; RP, red pulp; IF, interfollicular area.
Histopath, histopathological grading for lymphoid morphology. The histopathological findings for each component are indicated as follows: NP, normal
appearance; TBM, tingible body macrophages; IN, infiltration of the neutrophils; MA, moderate atrophy; SA, severe atrophy with lobular collapse; HM,
hyperplasia with mixed cell infiltration; H, hyperplasia; DP, depletion; NA, samples not available for study. HISH, histochemical in situ hybridization. Results
of HISH were quantified as follows: () no positive cell; () 1 to 5 positive cells per section; () 1 to 5 positive cells per high-power field (HPF  400
magnification); () 6 to 15 positive cells per HPF; () greater than 15 positive cells per HPF.
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progression was not clear, especially in the early phase of
infection. Notably, even the SIV-infected animals that had
developed AIDS did not show as much thymic atrophy as was
observed in the SHIV89.6P infected animals. In this study, we
examined the early stage of pathogenic and nonpathogenic
SHIV infections.
All four SHIV89.6P-infected monkeys exhibited severe
CD4 T-cell loss in PBMCs within 14 dpi. Interestingly,
despite this observation, the histology of LNs showed para-
cortical expansion with infiltration of mixed cell types, and
the paracortical depletion was delayed to 28 dpi. The peak
incidence of the VPCs identified by the HISH analyses
seemed to be lower than that seen in the SIVmac239-
infected LNs. In fact, most of them disappeared by 28 dpi.
Their disappearance was proportional to the paracortical
depletion. The paracortical depletion was not found to be
associated with either the florid follicular hyperplasia or the
resultant follicular depletion, although this type of lesion
was usually seen in the SIVmac239 infections. These find-
ings suggest that the profound CD4 cell depletion in the
peripheral blood is a direct reflection of the cell loss caused
by the SHIV89.6P infection rather than by redistribution of
the infected cells. Wallace et al. (1999) reported that CD4
T cells are highly activated during acute infection with
SHIV89.6PD (a separate isolate of SHIV89.6P) and are
unusually susceptible to activation-induced cell death. We
previously observed an increased frequency of apoptotic
cells in the SHIV89.6P-infected LNs and thymic cortex at
the early stage of the infection (Iida et al., 2000). Together,
the severe paracortical cell loss without follicular activation
seemed to be caused by apoptotic cell death. The high
frequency of apoptotic cell death could not be explained
only by the cell death directly due to infection with
SHIV89.6P because of the low incidence of VPCs.
Our observations indicated that acute thymic involution
with a “starry sky” appearance in the cortex prior to severe
atrophy was one of the most characteristic in the early stage
of SHIV89.6P infection. Thymic involvement has been re-
Fig. 3. (A) Representative histology of the early stage of SHIV89.6P-infected thymuses at 14 dpi (H&E). (Left) 40; (middle) cortex region, 400; (right)
medulla region,400. (B, C) Intrathymic distribution of VPCs in the early stage of infection. H&E on left side and histochemical in situ hybridization (HISH)
staining on right side are shown, respectively. (B) SHIV89.6P-infected thymus at 14 dpi (left, 100; right, 400). (C) SHIV89.6P-infected (left),
NM-3rN-infected (middle), and SIVmac239-infected (right) thymus at 28 dpi (100).
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ported in humans (Burke et al., 1995; Prevot et al., 1992), in
macaques (Li et al., 1995; Muller et al., 1993; Wykr-
zykowska et al., 1998), and in HIV-1-infected thymic im-
plants in SCID-hu mice (Bonyhadi et al., 1993; Ogura et al.,
1996). The three major features of the thymic alterations in
HIV-infected children and infants are thymitis, precocious
thymic involution, and thymic dysinvolution (Joshi et al.,
1986). The thymitis was attributed to the formation of lym-
phoid follicles in the infected medullae. This was observed
at a relatively late stage of SIVsm-infected cynomolgous
monkeys and seropositive asymptomatic drug addicts (53 to
783 dpi, respectively) (Li et al., 1995; Prevot et al., 1992).
One of these studies (Wykrzykowska et al., 1998) described
scattered VPCs exhibiting a lymphoid morphology in the
medulla as early as 7 dpi. The SHIV89.6P-infected thy-
muses at this stage did not show a significant follicular
aggregation in the medullae as was observed in the SIV-
infected animals. Instead, the thymus revealed an abun-
dance of tingible-body macrophages in the cortex accom-
panied by various degrees of neutrophilic infiltration in the
medulla at 14 dpi. This alteration was followed by thymic
involution with reduction of VPCs at 28 dpi. Interestingly,
the VPCs that were identified in the infected medulla had a
spindle shape and a network distribution. Morphologically
these seemed to be thymic stromal cells. Similar cell pop-
ulations and a similar tissue distribution were described in
HIV-1-infected thymic implants in SCID-hu mice (Bony-
hadi et al., 1993; Okamoto et al., 1998). We noted the
peripheral lymphoid depletion in the LNs, spleens, and
tonsils in the early stage of SHIV89.6P infections. Taken
together, these results seem to indicate that the acute phase
of SHIV89.6P infection is characterized by acute thymic
involution with generalized lymphoid depletion. In humans,
an acute “stress” involution was noted in children undergo-
Fig. 4. Representative TEM images derived from SHIV89.6P-infected thymuses at 14 dpi (left) and 28 dpi (right) (1600). E1, subcapsular cells; E2, pale
cells; E4, dark epithelial cells; E6, large medullary epithelial cells; H, Hassall’s corpuscles; and BL, basal lamina. The morphological classification of the
thymic epithelial cells was according to the reference Shimosato and Mukai (1997).
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ing major stress, such as occurs with extensive thermal
injury, radiotherapy, anti-tumor therapy, chorioamnionitis,
and sepsis (Shimosato and Mukai, 1997; Suster and Rosai,
1992; Toti et al., 2000). The histology of the stress involu-
tion was known as acute cortical shrinkage associated with
a starry sky appearance, and it was similar to that seen in the
SHIV89.6P infection (Fig. 3A and Toti et al., 2000). This
accidental or stress-associated involution appears to result
from a sudden release of corticosteroid from the adrenal
cortex, which causes rapid lympholysis of the cortical thy-
mocytes (Cowan and Sorenson, 1964). Some of the thymic
epithelial cells were thought to be secreting thymic pep-
tides, such as thymosin fraction 5, which modulate the
hypothalamo–pituitary–adrenal axis by affecting the release
of adrenocorticotropic hormone (Goya et al., 1993). Inter-
estingly, we observed densely packed VPCs in the thymic
medulla followed by the disruption of the E4 cell network in
the SHIV89.6P-infected animals. As mentioned above, the
virus did not seem to directly kill many infected cells in the
lymph nodes. Taken together, these results suggest that the
CD4 depletion in the SHIV89.6P-infected animals is due to
stress involution induced by viral infection and that the
generation of CD4 cells in its lineage is inhibited. Expres-
sion of interleukin-7, a cytokine produced by thymic stro-
Table 3
Histopathology and distribution of virus producing cells in sequentially resected peripheral lymph nodes
Virus Animal ID Pre-inoculation 5 dpi 14 dpi 28 dpi
Histopath
FL/PC/S
HISH
FL/PC/S
Histopath
FL/PC/S
HISH
FL/PC/S
Histopath
FL/PC/S
HISH
FL/PC/S
Histopath
FL/PC/S
HISH
FL/PC/S
SHIV89.6P MM180 NP/NP/NP // NP/NP/NP // NP/HM/SH // NA NA
MM184 NP/NP/NP // NP/NP/NP // NP/HM/SH // NA NA
MM159 NP/NP/NP // NP/NP/NP // NP/HM/SH // H/DP/SH //
MM161 NP/NP/NP // NP/NP/NP // NP/HM/SH // H/DP/SH //
NM-3rN MM168 NP/NP/NP // NP/NP/NP // NP/NP/NP // NA NA
MM172 NP/NP/NP // NP/NP/NP // NP/NP/NP // NA NA
MM139 NP/NP/NP // NP/NP/NP // NP/NP/NP // NP/H/SH //
MM157 NP/NP/NP // NP/NP/NP // NP/NP/NP // NP/H/SH //
SIVmac239 MM2013 NP/NP/NP // NP/NP/NP // NP/H/SH // NP/HM/SH //
MM2015 NP/NP/NP // NP/NP/NP // NA NA NP/HM/SH //
MM2019 NP/NP/NP // NP/NP/NP // NP/H/SH // NP/HM/SH //
Note. Abbreviations for anatomical sites: FL, follicles; PC, paracortex; S, sinus. Histopath, histopathological grading for lymphoid morphology. The
histopathological findings for each component are indicated as follows: NP, normal appearance; HM, hyperplasia with mixed cell infiltration; SH, sinus
histiocytosis; H, hyperplasia; DP, depletion; NA, samples not available for study. The frequencies of VPCs in tissue sections detected by HISH are indicated
as described in Table 2.
Fig. 5. Representative tissue distributions of VPCs in sequentially resected LNs. The HISH staining of the sequentially resected LNs is shown. SHIV89.6P-,
NM-3rN-, and SIVmac239-infected LNs are arranged from left to right, respectively. The left-side image in each panel shows H&E at the indicated period,
while the right-side image shows HISH of sequential sections.
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mal cells and known to play a key role in T cell develop-
ment, in HIV-1-positive individuals correlates with CD4
T cell depletion (Llano et al., 2001). Further investigations
are needed to clarify the humoral factors involved in im-
mune modulations.
As the thymic atrophy caused by the SHIV89.6P infec-
tion was so profound, the regeneration of the T cell pool
would be expected to be impaired and the resultant T cell
repertoire would be expected to be extremely limited. Such
a limitation together with the paracortical depletion of the
lymph nodes might explain the rapid, profound, and “con-
tinuous” T cell depletion in the SHIV89.6P-infected ani-
mals. This rapid and drastic clinical course is clearly dif-
ferent from that observed in HIV-1-infected humans.
However, SHIV and HIV-1 share several properties: SHIV
has several HIV-1 genes including env, the same CD4 T
lymphocyte subset that is depleted in HIV-1-infected hu-
mans is depleted in SHIV-infected monkeys, and the symp-
toms of the induced immunodeficiency in the SHIV-in-
fected monkeys are also very similar to those observed in
HIV-1-infected individuals (Douek et al., 1998). Further-
more, the infectivity of thymocytes was found to be closely
associated with the CD4 depletion by HIV-1 in vivo (Stod-
dart et al., 2001). Therefore, the acute pathogenicity of
SHIV89.6P in macaques can be viewed as a model of
human AIDS with a markedly compressed clinical course
and should be quite useful for further investigation of the in
vivo mechanism of AIDS pathogenesis.
As we reported previously, NM-3rN replicated as fast as
the parental SIVmac239 in human and macaque PBMCs
and in several CD4 human cell lines (Kuwata et al., 1995).
Chronic persistent infections have been established in rhe-
sus, pig-tailed, and cynomolgous monkeys (Hayami et al.,
1999; Kuwata et al., 1995). In the very early stage of
infection, the cell-associated virus loads of NM-3rN were
comparable with those of SIVmac239 and they thereafter
declined to a 10- to 100-fold lower level (Kuwata et al.,
1995), while the plasma virus load, which is more sensitive
than the cell-associated virus load, showed that NM-3rN has
a lower growth ability in vivo (Fig. 2). Our study indicated
that there was an activation of the infected LNs (as demon-
strated by paracortical expansion with mixed cellular
infiltration) at 28 dpi in both the NM-3rN- and SIVmac239-
infected animals. The NM-3rN-infected monkeys subse-
quently showed follicular hyperplasia in the chronic state of
infection. Nevertheless, the infected germinal centers did
not show any involuted features and the frequencies of
occurrence of VPCs and the amounts of proviral DNA were
Fig. 6. Proviral DNA quantification in SHIV89.6P- or NM-3rN-infected lymphoid tissues (thymus, spleen, and mesenteric LN).
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significantly lower than those seen in the pathogenic
SHIV89.6P-infected monkeys. The generalized lymphoid
activation with the minimal involution and reduced fre-
quency of VPCs in the lymphoid tissues seemed to be the
main features of the NM-3rN infection. These results were
similar to those observed in human long-term nonprogres-
sors (Pantaleo et al., 1995). Thus, the in vivo NM-3rN
proliferation did not cause extreme lymphoid activation
such as persistent generalized lymphadenopathy, and there-
fore it may provide a good model for long-term nonprogres-
sors. Further studies are needed to clarify the mode of
infection at the early stage of long-term nonprogressive
infection, which cannot be predicted in humans.
The tissue distributions of SHIV89.6P and SIVmac239
were clearly different although the viral load set points at 28
dpi for the two viruses were similar. The different tissue
tropisms of these viruses seem to be due to a difference in
the coreceptors that they use. That is, SIVmac239 uses
CCR5, and SHIV89.6P uses both CCR5 and CXCR4. Other
acute pathogenic SHIV strains causing rapid CD4 cell
depletion are also known to use CXCR4 only or both
CXCR4 and CCR5, whereas infection with a pathogenic
CCR5-specific enveloped virus, SHIVSF162P, caused a
dramatic loss of CD4 intestinal T cells followed by a
gradual depletion in peripheral CD4 T cells (Harouse et
al., 1999; Igarashi et al., 1999; Joag et al., 1996). NM-3rN
has the env of an HIV-1 strain that is derived from the
NL432 strain and uses CXCR4 as a coreceptor but replica-
tion of NM-3rN in vivo is limited. The rapid CD4 T cell
depletion that occurs in peripheral blood at the early stage of
infection may require the usage of the CXCR4 coreceptor
and a high virus load set point.
In conclusion, the early stage of the SHIV89.6P infection
was characterized by acute thymic involution and paracor-
tical lymphadenitis which began within 14 dpi. Because of
the severe pathological alterations and the profound periph-
eral CD4 cell loss caused by SHIV89.6P, the infection in
macaques is useful for analyzing the in vivo mechanism of
AIDS pathogenesis. In contrast, NM-3rN showed general-
ized lymphoid activation with minimal involution and these
pathological findings were similar to those seen in human
long-term nonprogressors. NM-3rN induced strong immu-
nological responses and resulted in minimal cell loss caused
by apoptosis. Clarification of the mechanisms responsible
for the disease-free state in NM-3rN infection might provide
insights for preventing pathogenic virus infections. Also,
the nonpathogenic features of NM-3rN might make this
virus suitable as a prototype for live-attenuated vaccines.
Materials and methods
SHIV
The detailed protocol for generation of NM-3rN has been
described (Kuwata et al., 1995). SHIV89.6P was kindly
provided by Dr. K.A. Reimann and Dr. N.L. Letvin
(Reimann et al., 1996a). The pathogenic molecular clone,
SIVmac239, was kindly provided by Dr. R.C. Desrosiers
(Naidu et al., 1988). The plasmid DNAs of NM-3rN and
SIVmac239 were transfected into M8166 cells (Clapham et
al., 1987) and infectious viruses were obtained. Rhesus
macaque PBMCs were infected with these viruses and the
supernatant with the highest reverse transcriptase activity
level was used as the virus stock. The TCID50 values of
these stock viruses were determined using M8166 cells and
were adjusted by adding an appropriate volume of medium.
Animal experiments
Monkeys were treated in accordance with the institu-
tional regulations approved by the Committee for Experi-
mental Use of Nonhuman Primate in the Institute for Virus
Research, Kyoto University. As references for the AIDS
state, two SHIV89.6P-infected monkeys (MM130 and
MM131) and two SIVmac239-infected monkeys (MM082
and MM105) were observed until they showed the initial
symptoms of the disease. Two NM-3rN-infected monkeys
were followed up for more than 3 years (Table 1). A total of
eight young rhesus monkeys (Macaca mulatta, 3 to 6 years
old) were infected with either SHIV89.6P or NM-3rN. Two
monkeys for each incubation period (14 and 28 days) were
employed. For positive controls of viral infection, we ex-
amined three SIVmac239-infected monkeys for 28 days
(Tables 2 and 3). All of these monkeys were confirmed to be
free of SIV and simian T-cell leukemia/lymphoma virus
type 1 (STLV-1). The animals were intravenously inocu-
lated with 10 TCID50 of SHIV89.6P or NM-3rN or with 105
TCID50 of SIVmac239. The peripheral LNs were sequen-
tially removed to examine the histopathological alterations.
The blood samples were periodically monitored by CD4
cell counts and by determining the plasma virus load as
described (Kozyrev et al., 2001). At 14 and 28 dpi, the
SHIV89.6P- and NM-3rN-infected animals were euthanized
and necropsied for subsequent histopathological examina-
tions. The thymus, spleen, tonsil, and peripheral LN (axil-
lary, inguinal, and mesenteric) derived from an identical
animal were either fixed in 4% paraformaldehyde (PFA)–
PBS overnight at 4°C, and then embedded in paraffin wax
for the histological examinations and histochemical in situ
hybridization (HISH) studies, or directly frozen for DNA
extraction.
Histopathological examination
The tissue sections were cut at a thickness of 4 m and
stained with hematoxylin–eosin (H&E) for the subsequent
histopathological examinations. Histological alterations of
the viral-infected macaques were classified according to a
previous report (Ringler et al., 1989). To examine alter-
ations in the tissue, some of the PFA-fixed and paraffin-
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embedded thymic tissues were excised, deparaffinized, and
subjected to transparent electron microscopy (TEM).
Histochemical in situ hybridization (HISH)
Digoxigenin-labeled antisense RNA probes were em-
ployed for the HISH detection of the viral genomes (DIG–
RNA, Bo¨ehringer–Mannheim, Tokyo, Japan) (Bucy et al.,
1994; Karr et al., 1994). Briefly, 4-m-thick paraffin sec-
tions were deparaffined and subjected to 0.2 M HCl degen-
eration followed by Proteinase K (PK; Sigma–Aldrich Ja-
pan, Tokyo) digestion and acetylation. The conditions of PK
treatment (4 g/ml in PBS at 37°C for 30 min) were deter-
mined by preliminary tests. After postfixation, the sections
were prehybridized for 1 h at room temperature and hybrid-
ized overnight at 42°C with 5 ng/section of the DIG–RNA
probes. Following RNase treatment and extensive washing,
the hybrids were incubated with alkaline phosphatase-con-
jugated antidigoxigenin antibody (Fab fractionated) and the
resultant complexes were visualized by NBT/BCIP sub-
strates (Bo¨ehringer–Mannheim, Tokyo, Japan) at 4°C for
40 h.
For an RNA probe, we synthesized and tested several
candidates such as the gag, pol, or nef regions, which were
raised against almost identical sequences among SIV-
mac239, NM-3rN, and SHIV89.6P. We eventually selected
a 562-nucleotide region in nef because it gave the strongest
and most reproducible signals. Viral distributions were es-
timated by the number of VPCs per high power (400) field
under the microscope.
Quantitative analysis of provirus DNA
The SHIV proviral DNA quantitative assay was per-
formed with TaqMan DNA PCR (Perkin–Elmer, USA) for
the SIV gag region using the primers SIVII-696F (5-
GGAAATTACCCAGTACAACAAATAGG-3) and SI-
VII-784R (5-TCTATCAATTTTACCCAAGGCATTTA-
3). DNA samples were extracted directly from frozen
lymphoid tissues with a QIAGEN DNeasy Tissue kit (QIA-
GEN, Germany) according to the manufacturer’s protocol.
A labeled probe, SIVII-731T (5-Fam-TGTCCACCTGC-
CATTAAGCCCG-Tamra-3), was used for detection of the
PCR product. For each run, a standard curve was generated
from a plasmid DNA sample containing the full genome of
SHIV NM-3rN, which was quantified with a UV spectro-
photometer.
Acknowledgments
We sincerely thank Drs. K.A. Reimann and N.L. Letvin
of Beth Israel Hospital, Boston, for kindly providing
SHIV89.6P. We thank Keijiro Tamaru, Tsutomu Obata,
Yoshinobu Toda, and Makio Fujioka for expert assistance
in tissue processing and pathological examinations; Kyoko
Yokoyama for technical support of quantitative provirus
DNA PCR; James Raymond for professional English edit-
ing; and Drs. Tatsuhiko Igarashi, Hiromi Kubagawa, R. Pat
Bucy, and Cynthia Derdeyn for their helpful discussions
and encouragement. This work was supported by grants-in-
aid for AIDS research from the Organization for Drug
Relief, R&D Promotion and Product Review, a Grant-in-
Aid for Scientific Research from the Ministry of Education
and Science, Japan, and a Research Grant on Health Sci-
ences focusing on Drug Innovation from Japan Health Sci-
ences Foundation.
References
Bonyhadi, M., Rabin, L., Salimi, S., Brown, D.A., Kosek, J., McCune,
J.M., Kaneshima, H., 1993. HIV induces thymus depletion in vivo.
Nature 363, 728–732.
Bucy, R.P., Panoskaltsis-Mortari, A., Huang, G.Q., Li, J., Kerr, L., Ross,
M., Russel, J.H., Murphy, K.M., Weaver, C.T., 1994. Heterogeneity of
single cell cytokine gene expression in clonal T cell populations. J.
Exp. Med. 180, 1251–1262.
Burke, A.P., Anderson, D., Benson, W., Turnicky, R., Mannan, P., Liang,
Y.H., Smialek, J., Virmani, R., 1995. Localization of human immuno-
deficiency virus in thymic tissues from asymptomatic drug addicts.
Arch. Pathol. Lab. Med. 119, 36–41.
Chakrabarti, L., Isola, P., Cumont, M.C., Claessens-Maire, M.A., Hurtrel,
M., Montagnier, L., Hurtrel, B., 1994. Early stages of simian immu-
nodeficiency virus infection in lymph nodes: evidence for high viral
load and successive population of target cells. Am. J. Pathol. 144,
1226–1237.
Clapham, P.R., Weiss, R.A., Dalgleish, A.G., Exley, M., Whitby, D.,
Hogg, N., 1987. Human immunodeficiency virus infection of mono-
cytic and T-lymphocytic cells: receptor modulation and differentiation
induced by phorbol ester. Virology 158, 44–51.
Cowan, W.K., Sorenson, G.D., 1964. Electron microscopic observations of
acute thymic involution produced by hydrocortisone. Lab. Invest. 13,
353–370.
Daniel, M.D., Letvin, N.L., King, N.W., Kannagi, M., Sehgal, P.K., Hunt,
R.D., Kanki, P.J., Essex, M., Desrosiers, R.C., 1985. Isolation of a
T-cell tropic HTLV-III-like retrovirus from macaques. Science 228,
1201–1204.
Douek, D.C., McFarland, R.D., Keiser, P.H., Gage, E.A., Massey, J.M.,
Haynes, B.F., Polis, M.A., Haase, A.T., Feinberg, M.B., Sullivan, J.L.,
Jamieson, B.D., Zack, J.A., Picker, L.J., Koup, R.A., 1998. Changes in
thymic function with age and during the treatment of HIV infection.
Nature 396, 690–695.
Fauci, A.S., 1993. Multifactorial nature of human immunodeficiency virus
disease: implications for therapy. Science 262, 1011–1017.
Goya, R.G., Castro, M.G., Hannah, M.J., Sosa, Y.E., Lowry, P.J., 1993.
Thymosin peptides stimulate corticotropin release by a calcium-depen-
dent mechanism. Neuroendocrinology 57 (2), 230–235.
Graziosi, C., Soudeyns, H., Rizzardi, G.P., Bart, P.-A., Chapuis, A., Pan-
taleo, G., 1998. Immunopathogenesis of HIV infection. AIDS Res.
Hum. Retroviruses 14, 135–142.
Haga, T., Kuwata, T., Ui, M., Igarashi, T., Miyazaki, Y., Hayami, M.,
1998. A new approach to AIDS research and prevention: the use of
gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live attenu-
ated vaccines. Microbiol. Immunol. 42, 245–251.
Harouse, J.M., Gettie, A., Eshetu, T., Tan, R.C., Bohm, R., Blanchard, J.,
Baskin, G., Cheng-Mayer, C., 2001. Mucosal transmission and induc-
tion of simian AIDS by CCR5-specific simian/human immunodefi-
ciency virus SHIV(SF162P3). J. Virol. 75 (4), 1990–1995.
344 T. Shimada et al. / Virology 306 (2003) 334–346
Harouse, J.M., Gettie, A., Tan, R.C., Blanchard, J., Cheng-Mayer, C.,
1999. Distinct pathogenic sequela in rhesus macaques infected with
CCR5 or CXCR4 utilizing SHIVs. Science 284 (5415), 816–819.
Hayami, M., Igarashi, T., Kuwata, T., Ui, M., Haga, T., Ami, Y., Shino-
hara, K., Honda, M., 1999. Gene-mutated HIV-1/SIV chimeric viruses
as AIDS live attenuated vaccines for potential human use. Leukemia
13, S42–S47.
Igarashi, T., Endo, Y., Englund, G., Sadjadpour, R., Matano, T., Buckler,
C., Buckler-White, A., Plishka, R., Theodore, T., Shibata, R., Martin,
M., 1999. Emergence of a highly pathogenic simian/human immuno-
deficiency virus in a rhesus macaque treated with anti-CD8 mAb during
a primary infection with a nonpathogenic virus. Proc. Natl. Acad. Sci.
USA 96 (24), 14049–14054.
Igarashi, T., Kuwata, T., Takehisa, J., Ibuki, K., Shibata, R., Mukai, R.,
Komatsu, T., Adachi, A., Ido, E., Hayami, M., 1996. Genomic and
biological alteration of a human immunodeficiency virus type 1 (HIV-
1)-simian immunodeficiency virus strain mac chimera, with HIV-1 env,
recovered from a long-term carrier monkey. J. Gen. Virol. 77, 1649–
1658.
Igarashi, T., Shibata, R., Hasebe, F., Ami, Y., Shinohara, K., Komatsu, T.,
Stahl-Henning, G., Petry, H., Hunsmann, G., Miura, T., Hayami, M.,
1994. Persistent infection with SIVmac chimeric virus having tat, rev,
vpu, env and nef of HIV-1 in macaque monkeys. AIDS Res. Hum.
Retroviruses 10, 1021–1029.
Iida, T., Ichimura, H., Shimada, T., Ibuki, K., Ui, M., Tamaru, K., Kuwata,
T., Yonehara, S., Imanishi, J., Hayami, M., 2000. Role of apoptosis in
both peripheral lymph nodes and thymus in progressive loss of CD4
cells in SHIV-infected macaques. AIDS Res. Hum. Retroviruses 16 (1),
9–18.
Joag, S.V., Li, Z., Foresman, L., Stephens, E.B., Zhao, L.J., Adany, I.,
Pinson, D.M., McClure, H.M., Narayan, O., 1996. Chimeric simian/
human immunodeficiency virus that causes progressive loss of CD4
T cells and AIDS in pig-tailed macaques. J. Virol. 70 (5), 3189–3197.
Joshi, V.V., Oleske, J.M., Saad, S., Gadol, C., Connor, E., Bobila, R.,
Minnefor, A.B., 1986. Thymus biopsy in children with acquired im-
munodeficiency syndrome. Arch. Pathol. Lab. Med. 110 (9), 837–842.
Karr, L.J., Panoskaltsis-Mortari, A., Li, J., Devore-Carter, D., Weaver,
C.T., Bucy, R.P., 1994. In situ hybridization for cytokine mRNA with
digoxigenin-labeled riboprobes. Sensitivity of detection and double
label applications. J. Immunol. Methods 182, 93–106.
Kozyrev, I.L., Ibuki, K., Shimada, T., Kuwata, T., Takemura, T., Hayami,
M., Miura, T., 2001. Characterization of less pathogenic infectious
molecular clones derived from acute-pathogenic SHIV-89.6p stock
virus. Virology 282 (1), 6–13.
Kuwata, T., Igarashi, T., Ido, E., Jin, M., Mizuno, A., Chen, J., Hayami,
M., 1995. Construction of human immunodeficiency virus 1/simian
immunodeficiency virus strain mac chimeric viruses having vpr and/or
nef of different parental origins and their in vitro and in vivo replica-
tion. J. Gen. Virol. 76, 2181–2191.
Lackner, L.A., Vogel, P., Ramos, R.A., Kluge, J.D., Marthas, M., 1994.
Early events in tissues during infection with pathogenic (SIVmac239)
and nonpathogenic (SIVmac1A11) molecular clones of simian immu-
nodeficiency virus. Am. J. Pathol. 145, 428–439.
Letvin, N.L., Daniel, M.D., Sehgal, P.K., Desrosiers, R.C., Hunt, R.D.,
Waldron, L.M., MacKey, J.J., Schmidt, D.K., Chalifoux, L.V., King,
N.W., 1985. Induction of AIDS-like disease in macaque monkeys with
T-cell tropic retrovirus STLV-III. Science 230, 71–73.
Letvin, N.L., King, N.W., 1990. Immunologic and pathologic manifesta-
tions of the infection of rhesus monkeys with simian immunodeficiency
virus of macaques. J. AIDS 3, 1023–1040.
Li, S.L., Kaaya, E.E., Ordonez, C., Ekman, M., Feichtinger, H., Putkonen,
P., Bottiger, D., Biberfeld, G., Biberfeld, P., 1995. Thymic immuno-
pathology and progression of SIVsm infection in cynomolgous mon-
keys. J. AIDS Hum. Retrovirol. 9, 1–10.
Llano, A., Barretina, J., Gutierrez, A., Blanco, J., Cabrera, C., Clotet, B.,
Este, J.A., 2001. Interleukin-7 in plasma correlates with CD4 T-cell
depletion and may be associated with emergence of syncytium-induc-
ing variants in human immunodeficiency virus type 1-positive individ-
uals. J. Virol. 75 (21), 10319–10325.
Madea, B., Roewert, H.J., Krueger, G.R., Ablashi, D.V., Josephs, S.F.,
1990. Search for early lesions following human immunodeficiency
virus type 1 infection: a study of six individuals who died a violent
death after seroconversion. Arch. Pathol. Lab. Med. 114, 379–382.
Muller, J.G., Kernn, V., Schindler, C., Czub, S., Stahl-Henning, C., Cou-
libaly, C., Hunsmann, G., Kneitz, C., Kerkau, T., Rethwiln, A., ter-
Meulen, V., Muller-Hermelink, H.K., 1993. Alterations of thymus
cortical epithelium and interdigitating dendritic cells but no increase of
thymocyte cell death in the early course of simian immunodeficiency
virus infection. Am. J. Pathol. 143, 699–713.
Naidu, Y.M., Kestler III, H.W., Li, Y., Butler, C.V., Silva, D.P., Schmidt,
D.K., Troup, C.D., Sehgal, P.K., Sonigo, P., Daniel, M., Desrosiers,
R.C., 1988. Characterization of infectious molecular clones of simian
immunodeficiency virus (SIVmac) and human immunodeficiency virus
type 2: persistent infection of rhesus monkeys with molecularly cloned
SIVmac. J. Virol. 62, 4691–4696.
Ogura, A., Noguchi, Y., Yamamoto, Y., Shibata, S., Asano, T., Okamoto,
Y., Honda, M., 1996. Localization of HIV-1 in human thymic implant
in SCID-hu mice after intravenous inoculation. Int. J. Exp. Pathol. 77,
201–206.
Okamoto, Y., Eda, Y., Ogura, A., Shibata, S., Amagai, T., Katsura, Y.,
Asano, T., Kimachi, K., Makizumi, K., Honda, M., 1998. In SCID-hu
mice, passive transfer of a humanized antibody prevents infection and
atrophic change of medulla in human thymic implant due to intrave-
nous inoculation of primary HIV-1 isolate. J. Immunol. 160, 69–76.
Pantaleo, G., Graziosi, C., Demarest, J.F., Butini, L., Montroni, M., Fox,
C.H., Orenstein, J.M., Kotler, D.P., Fauci, A.S., 1993. HIV infection is
active and progressive in lymphoid tissue during the clinically latent
stage of disease. Nature 362, 355–358.
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O.J., De-
marest, J.F., Monte-fiori, D., Orenstein, J.M., Fox, C., Schrager, L.K.,
Margolick, J.B., Buchbinder, S., Giorgi, J.V., Fauci, A.S., 1995. Stud-
ies in subjects with long-term nonprogressive human immunodefi-
ciency virus infection. New Engl. J. Med. 332, 209–216.
Prevot, S., Audouin, J., Andre-Bougaran, J., Griffais, R., Le Tourneau, A.,
Fournier, J.G., Diebold, J., 1992. Thymic pseudotumorous enlargement
due to follicular hyperplasia in a human immunodeficiency virus sero-
positive patient, immunohistochemical and molecular biological study
of viral infected cells. Am. J. Clin. Pathol. 97, 420–425.
Reimann, K.A., Li, J.T., Veazey, R., Halloran, M., Park, I., Karlsson, G.B.,
Sodroski, J., Letvin, N.L., 1996a. A chimeric simian/human immuno-
deficiency virus expressing a primary patient human immunodeficiency
virus type 1 isolate env causes an AIDS-like disease after in vivo
passage in rhesus monkeys. J. Virol. 70, 6922–6928.
Reimann, K.A., Li, J.T., Voss, G., Lekutis, C., Tenner-Racz, K., Racz, P.,
Lin, W., Montefiori, D.C., Lee-Parritz, D.E., Lu, Y., Collman, R.G.,
Sodroski, J., Letvin, N.L., 1996b. An env gene derived from a primary
human immunodeficiency virus type 1 isolate confers high in vivo
replication capacity to a chimeric simian/human immunodeficiency
virus in rhesus monkeys. J. Virol. 70, 3198–3206.
Ringler, D.J., Wyand, M.S., Walsh, D.G., MacKey, J.J., Chalifoux, L.V.,
Popovic, M., Minassian, A.A., Sehgal, P.K., Daniel, M.D., Desrosiers,
R.C., King, N.W., 1989. Cellular localization of simian immunodefi-
ciency virus in lymphoid tissues. I. Immunohistochemistry and electron
microscopy. Am. J. Pathol. 134, 373–383.
Sakuragi, S., Shibata, R., Mukai, R., Komatsu, T., Fukasawa, M., Sakai,
H., Sakuragi, J., Kawamura, M., Ibuki, K., Hayami, M., Adachi, A.,
1992. Infection of macaque monkeys with a chimeric human and
simian immunodeficiency virus. J. Gen. Virol. 73, 2983–2987.
Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., Adachi,
A., 1991. Generation of a chimeric human and simian immunodefi-
ciency virus infectious to monkey peripheral blood mononuclear cells.
J. Virol. 65, 3514–3520.
345T. Shimada et al. / Virology 306 (2003) 334–346
Shimosato, Y., and Mukai, K. (1997). Tumors of the mediastinum. In
“Atlas of Tumor Pathology,” 3rd series, fascicle 21 vols. Armed Forces
Institute of Pathology, Washington, DC.
Stoddart, C.A., Liegler, T.J., Mammano, F., Linquist-Stepps, V.D., Hay-
den, M.S., Deeks, S.G., Grant, R.M., Clavel, F., McCune, J.M., 2001.
Impaired replication of protease inhibitor-resistant HIV-1 in human
thymus. Nat. Med. 7 (6), 712–718.
Suster, S., Rosai, J., 1992. Thymus. In Sternberg, S.S. (Ed.), Histology for
Pathologists. Raven Press, New York, pp. 261–277.
Toti, P., De Felice, C., Stumpo, M., Schurfeld, K., Di Leo, L., Vatti, R.,
Bianciardi, G., Buonocore, G., Seemayer, T.A., Luzi, P., 2000. Acute
thymic involution in fetuses and neonates with chorioamnionitis. Hum.
Pathol. 31 (9), 1121–1128.
Wallace, M., Waterman, P.M., Mitchen, J.L., Djavani, M., Brown, C., Trivedi,
P., Horejsh, D., Dykhuizen, M., Kitabwalla, M., Pauza, C.D., 1999. Lym-
phocyte activation during acute simian/human immunodeficiency virus
SHIV(89.6PD) infection in macaques. J. Virol. 73 (12), 10236–10244.
Weiss, R.A., Claphan, P.R., Weber, J.N., Dalgleish, A.G., Lasky, L.A.,
Berman, P.W., 1986. Variable and conserved neutralization antigens of
human immunodeficiency virus. Nature 324, 572–575.
Wenig, B.M., Thompson, L.D.R., Frankel, S.S., Burke, A.P., Abbondanzo,
S.L., Sester-henn, I., Heffner, D.K., 1996. Lymphoid changes of the
nasopharyngeal and palatine tonsils that are indicative of human im-
munodeficiency virus infection: a clinicopathologic study of 12 cases.
Am. J. Surgical Pathol. 20 (5), 572–587.
Wyand, M.S., Ringler, D.J., Naidu, Y.M., Mattmuller, M., Chalifoux, L.V.,
Sehgal, P.K., Daniel, M.D., Desrosiers, R.C., King, N.W., 1989. Cel-
lular localization of simian immunodeficiency virus in lymphoid tis-
sues. II. In situ hybridization. Am. J. Pathol. 134, 385–393.
Wykrzykowska, J., Rosenzweig, M., Veazey, R.S., Simon, M.A., Hal-
vorsen, K., Desrosiers, R.C., Johnson, R.P., Lackner, A.A., 1998.
Early regeneration of thymic progenitors in rhesus macaques in-
fected with simian immunodeficiency virus. J. Exp. Med. 187,
1767–1778.
346 T. Shimada et al. / Virology 306 (2003) 334–346
